Headquarters
2 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC 27709, US
RESEARCH TRIANGLE PARK, NC, US
From the company
ENDACEA (RTP, NC) is a biopharmaceutical research and development company that has been at the forefront of biopharmaceutical R&D since 1996. Led by Constance Neely Wilson, M.D., the company outsources operations and develops innovations including a mutant plasmid cDNA for the A1 adenosine receptor as a treatment for cancer, and its lead compound A1 adenosine receptor antagonist, L-97-1, as an intravenous treatment for sepsis and acute renal failure.
2 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC 27709, US
Quantities, certifications, and timing.